Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00789893 · ClinicalTrials.gov registry record

Study of Vaginal Dilator Use After Pelvic Radiotherapy

A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.

Completed
Registry status
115
Enrollment target

NCT00789893: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.

NCT00789893 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 115 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT00789893 has completed, sponsored by Memorial Sloan Kettering Cancer Center.

COMPLETED
Registry status
115 participants
Enrollment target

Study Summary

Patient will have radiation to treat the cancer. This treatment can make the vagina both narrower and shorter. That can cause two problems. It can make it harder for the doctor to do a pelvic exam during a follow-up visits. And, it can make sexual intercourse uncomfortable. We tell women to use a vaginal dilator after radiation to the pelvis. This is standard education. We do not routinely ask women how they do with it. We are doing this study to see if using the dilator as we instruct will help the vagina stretch. The patient will have an examine of the vagina before the start of radiation. We will see what size dilator can fit. The goal of this study is to have the patient be able to use that size dilator within six months after radiation.

Interventions

  • DEVICE Vaginal Dilator

Trial Details

FieldValue
Enrollment Target 115 participants
Start Date 2008-11
Est. Completion 2015-06
Memorial Sloan Kettering Cancer Center

1,884 total trials

What the finished NCT00789893 record still lists

NCT00789893 is an observational study that tracks outcomes without assigning an intervention. The registered 115 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 1 intervention - of which Vaginal Dilator is the first listed.

NCT00789893 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00789893 about?

NCT00789893 is a clinical study titled "Study of Vaginal Dilator Use After Pelvic Radiotherapy". Patient will have radiation to treat the cancer. This treatment can make the vagina both narrower and shorter. That can cause two problems. It can make it harder for the doctor to do a pelvic exam during a follow-up visits. And, it can make sexual intercourse uncomfortable. We tell women to use a v...

What is the current status of trial NCT00789893?

This trial is currently completed. The enrollment target is 115 participants. The study started on 2008-11. Estimated completion is 2015-06.

What interventions are being tested in trial NCT00789893?

The interventions under investigation include: Vaginal Dilator (DEVICE).

Who is sponsoring clinical trial NCT00789893?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02346929 · 115 participants · NA

    Hematoma Block for Distal Radius Fracture

  • NCT03394365 · 115 participants · Phase 3

    A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy

  • NCT03907475 · 115 participants · Phase 2

    Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial

  • NCT05086692 · 115 participants · Phase 1

    A Beta-only IL-2 ImmunoTherapY Study

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00789893, the US trial registry maintained by the National Library of Medicine. NCT00789893 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.